lacosamide
Generic: lacosamide
Labeler: pai holdings, llc dba pai pharmaDrug Facts
Product Profile
Brand Name
lacosamide
Generic Name
lacosamide
Labeler
pai holdings, llc dba pai pharma
Dosage Form
SOLUTION
Routes
Active Ingredients
lacosamide 200 mg/20mL
Manufacturer
Identifiers & Regulatory
Product NDC
0121-4048
Product ID
0121-4048_80024eb8-f6ab-420a-94df-dc5dd9ffb9b3
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA216151
DEA Schedule
cv
Listing Expiration
2026-12-31
Marketing Start
2022-08-26
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
01214048
Hyphenated Format
0121-4048
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lacosamide (source: ndc)
Generic Name
lacosamide (source: ndc)
Application Number
ANDA216151 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/20mL
Packaging
- 1 TRAY in 1 CASE (0121-4048-95) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-4048-74)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "80024eb8-f6ab-420a-94df-dc5dd9ffb9b3", "openfda": {"nui": ["N0000008486"], "unii": ["563KS2PQY5"], "rxcui": ["993856"], "spl_set_id": ["75de00d8-d2e7-4025-be4e-f49299068e7e"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["PAI Holdings, LLC dba PAI Pharma"]}, "finished": true, "packaging": [{"sample": false, "description": "1 TRAY in 1 CASE (0121-4048-95) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-4048-74)", "package_ndc": "0121-4048-95", "marketing_start_date": "20220826"}], "brand_name": "Lacosamide", "product_id": "0121-4048_80024eb8-f6ab-420a-94df-dc5dd9ffb9b3", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0121-4048", "dea_schedule": "CV", "generic_name": "Lacosamide", "labeler_name": "PAI Holdings, LLC dba PAI Pharma", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lacosamide", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "200 mg/20mL"}], "application_number": "ANDA216151", "marketing_category": "ANDA", "marketing_start_date": "20220826", "listing_expiration_date": "20261231"}